Structural Formula (Blu00 0000 01)
Bludigo Injection
Product Images NDC 25021-840
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bludigo (NDC 25021-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Ampule Label (Blu00 0000 02)
This is a description of a medication product labeled as "Bludigo - Indigotindisulfonate Sodium Injection, USP." It contains 40 mg per 5 mL (8 mg per mL) and is intended for intravenous use only. The product comes in a 5 mL single-dose ampule and any unused portion should be discarded. It was manufactured for SAGENT Pharmaceuticals in Schaumburg, IL, USA, and made in France. The text also indicates a copyright date of 2026, a batch number of 28072651, and an expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
